BHVN - Biohaven Pharmaceutical Holding Co Ltd - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BHVN is currently covered by 11 analysts with an average price target of $36.27. This is a potential upside of $18.36 (102.51%) from yesterday's end of day stock price of $17.91.

Biohaven Pharmaceutical Holding Co Ltd's activity chart (see below) currently has 9 price targets and 59 ratings on display. The stock rating distribution of BHVN is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 75.34% with an average time for these price targets to be met of 130.72 days.

Highest price target for BHVN is $76, Lowest price target is $54, average price target is $64.11.

Most recent stock forecast was given by TERENCE FLYNN from MORGAN STANLEY on 07-Mar-2025. First documented stock forecast 12-Oct-2022.

Currently out of the existing stock ratings of BHVN, 52 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$63

$44.41 (238.89%)

$69

1 months ago
(07-Mar-2025)

0/3 (0%)

$32.6 (107.24%)

Buy

$68

$49.41 (265.79%)

$68

1 months 2 days ago
(05-Mar-2025)

7/9 (77.78%)

$37.03 (119.57%)

56

Buy

$54

$35.41 (190.48%)

$59

1 months 3 days ago
(04-Mar-2025)

0/8 (0%)

$21.94 (68.43%)

Buy

3 months 21 days ago
(17-Dec-2024)

2/2 (100%)

$4.59 (17.38%)

185

Buy

$75

$56.41 (303.44%)

$55

4 months 25 days ago
(13-Nov-2024)

1/2 (50%)

$25.96 (52.94%)

3

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BHVN (Biohaven Pharmaceutical Holding Co Ltd) average time for price targets to be met?

On average it took 130.72 days on average for the stock forecasts to be realized with a an average price target met ratio 75.34

Which analyst has the current highest performing score on BHVN (Biohaven Pharmaceutical Holding Co Ltd) with a proven track record?

SUMANT KULKARNI

Which analyst has the most public recommendations on BHVN (Biohaven Pharmaceutical Holding Co Ltd)?

Sumant Kulkarni works at CANACCORD and has 9 price targets and 9 ratings on BHVN

Which analyst is the currently most bullish on BHVN (Biohaven Pharmaceutical Holding Co Ltd)?

Paul Choi with highest potential upside - $154.66

Which analyst is the currently most reserved on BHVN (Biohaven Pharmaceutical Holding Co Ltd)?

Matthew Harrison with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?